# The Use of Clinical Holds Following Clinical Investigator Misconduct:  Guidance for Industry and Clinical Investigators - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/the-use-of-clinical-holds-following-clinical-investigator-misconduct-guidance-for-industry-and-clinical-investigators/8baa9e6b-d386-4460-927e-2aa353d1ce2b

> FDA guidance document: The Use of Clinical Holds Following Clinical Investigator Misconduct:  Guidance for Industry and Clinical Investigators. Issue date: September 02, 2004. Get complete insights and analysis.

---

## Details

- Title: The Use of Clinical Holds Following Clinical Investigator Misconduct:  Guidance for Industry and Clinical Investigators
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2004-09-02
- Last Changed: 2020-05-06
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2002-D-0053">FDA-2002-D-0053</a>

## Related Documents

- [Independent Consultants for Biotechnology Clinical Trial Protocols:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/independent-consultants-for-biotechnology-clinical-trial-protocols-guidance-for-industry/5c1bd52a-26a6-498c-bb57-c7f0186d6bd4)
- [Submitting Separate Marketing Applications and Clinical Data for Purposes of Assessing User Fees:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/submitting-separate-marketing-applications-and-clinical-data-for-purposes-of-assessing-user-fees-guidance-for-industry/2c9aed18-87e7-4700-8c3b-593f58e268e8)
- [E9 Statistical Principles for Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/e9-statistical-principles-for-clinical-trials/d427b5ed-dd16-417e-adc2-9f35d3a3df23)